Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion type Assertion NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_head.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion description "[ZnT8 was therefore proposed as a therapeutic target for diabetes, and recent genome-wide association studies identified polymorphisms in the ZNT8 gene conferring increased type 2 diabetes risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_provenance.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion evidence source_evidence_literature NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_provenance.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion SIO_000772 19095428 NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_provenance.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion wasDerivedFrom befree-2016 NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_provenance.
- NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_assertion wasGeneratedBy ECO_0000203 NP710101.RAsLwbO7ypmAPSAvr3XVCLxArFCwRvUfPOkqHkfwLlkeA130_provenance.